G. Barratt et al., ANTIMETASTATIC ACTIVITY OF MDP-L-ALANYL-CHOLESTEROL INCORPORATED INTOVARIOUS TYPES OF NANOCAPSULES, International journal of immunopharmacology, 16(5-6), 1994, pp. 457-461
A lipophilic immunomodulator (MTP-Chol) was included in nanocapsules p
repared from different polymers and the anti-metastatic effects of the
resulting drug delivery systems were evaluated in a murine model of l
iver metastases. Loaded nanocapsules were effective if they were given
2 days before tumor inoculation. Neither the nature of the polymer no
r the total dose of immunomodulator affected the antimetastatic capaci
ty. However, enhanced anti-metastatic activity was obtained when indom
ethacin nanocapsules were associated with MTP-Chol nanocapsules. These
results show that nanocapsules containing an immunomodulator possess
antimetastatic activity, but only when given as a prophylactic treatme
nt; this would correspond, in the clinic, to patients undergoing surge
ry for a primary tumor and at risk of developing liver metastases.